People news

Share this article:
Aegerion Pharmaceuticals, a specialty manufacturer focused on cardiovascular and metabolic disease, has appointed Peter Garrambone, Jr., to the company's board of directors. Garrambone was previously a SVP, corporate strategic planning, at Pfizer.
 
SK&A, a marketing research firm, has promoted David Escalante, Jr., to president and CEO. Escalante was previously president and COO.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.